Therefore, upstream of stalled OGG1, there are candidate targets for AML treatment too: the cause of OGG1 stalling, being oxidative stress, affects the intracellular milieu through lipid peroxidation products, namely reactive aldehydes. This evidence concerns the gene OGG1 and acute myeloid leukemia.